sonrefund6
About
Cost-Effectiveness regarding Cetuximab as First-line Strategy to Metastatic Intestinal tract Cancer malignancy in the United States.
Cost-Effectiveness regarding Cetuximab as First-line Strategy to Metastatic Intestinal tract Cancer malignancy in the United States.